[Studies on subacute and chronic toxicity of butylmalonic acidmono-(1,2-diphenylhydrazide)calcium (bumadizone-calcium)].
D000818:Animals; D001066:Appetite / Q000187:drug effects; D001663:Bilirubin / Q000097:blood; D001772:Blood Cell Count; D001774:Blood Chemical Analysis; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D002118:Calcium / Q000633:toxicity; D002463:Cell Membrane Permeability / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D008099:Liver / Q000187:drug effects; D008297:Male; D008314:Malonates / Q000633:toxicity*; D010437:Peptic Ulcer / Q000139:chemically induced; D010659:Phenylhydrazines / Q000633:toxicity*; D012737:Sex Factors; D012964:Sodium / Q000633:toxicity; D013448:Sulfobromophthalein; D013997:Time Factors
D001786:Blood Glucose; D008314:Malonates; D010659:Phenylhydrazines; D013448:Sulfobromophthalein; D002784:Cholesterol; D012964:Sodium; D001663:Bilirubin; D002118:Calcium
Untersuchungen über die subakute und chronische Toxizität von Butyl-malonsäure-mono-(1,2-diphenyl-hydrazid)-Calcium (Bumadizon-Calcium.